Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Original Research
RANKL/RANK pathway abrogates cetuximab sensitivity in gastric cancer cells via activation of EGFR and c-Src
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,884 | Dovepress* | 7,218+ | 1,423 | 8,641 | |
| PubMed Central* | 666 | 275 | 941 | ||
| Totals | 7,884 | 1,698 | 9,582 | ||
| *Since 5 January 2017 | |||||
View citations on PubMed Central and Google Scholar